Back to Search
PADMAJA NAIDU, MD
MD
Diagnostic Radiology Physician
NPI: 1952512121IndividualAccepts Medicare
Specialties, Licenses & Credentials
Pediatric Radiology Physician
Radiology — Pediatric Radiology
Code: 2085P0229X
MD468791(PA)
Diagnostic Radiology PhysicianPrimary
Radiology — Diagnostic Radiology
Code: 2085R0202X
MD468791(PA)
CMS Specialties
PrimaryDIAGNOSTIC RADIOLOGY
Education
OTHER
Class of 2005
Research & Publications (20)
Synergy between enzyme inhibitors of fatty acid amide hydrolase and cyclooxygenase in visceral nociception.
PMID 19118134·J Pharmacol Exp Ther·2009
7-preclinical
Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality.
PMID 17279376·Psychopharmacology (Berl)·2007
7-preclinical
NIH 11082 produces anti-depressant-like activity in the mouse tail-suspension test through a delta-opioid receptor mechanism of action.
PMID 17459369·Eur J Pharmacol·2007
7-preclinical
Effect of Withania somnifera root extract on reserpine-induced orofacial dyskinesia and cognitive dysfunction.
PMID 16444668·Phytother Res·2006
7-preclinical
Reversal of reserpine-induced orofacial dyskinesia and cognitive dysfunction by quercetin.
PMID 14685008·Pharmacology·2004
7-preclinical
Quercetin, a bioflavonoid, reverses haloperidol-induced catalepsy.
PMID 15319809·Methods Find Exp Clin Pharmacol·2004
7-preclinical
D2-dopamine receptor and alpha2-adrenoreceptor-mediated analgesic response of quercetin.
PMID 15320492·Indian J Exp Biol·2003
7-preclinical
Possible mechanism of action in melatonin attenuation of haloperidol-induced orofacial dyskinesia.
PMID 12543230·Pharmacol Biochem Behav·2003
7-preclinical
Reversal of haloperidol-induced orofacial dyskinesia by quercetin, a bioflavonoid.
PMID 12669184·Psychopharmacology (Berl)·2003
4-observational
Quercetin, a bioflavonoid, attenuates haloperidol-induced orofacial dyskinesia.
PMID 12763102·Neuropharmacology·2003
7-preclinical
Effect of Withania somnifera root extract on haloperidol-induced orofacial dyskinesia: possible mechanisms of action.
PMID 12935321·J Med Food·2003
7-preclinical
Possible mechanisms of action in quercetin reversal of morphine tolerance and dependence.
PMID 13129835·Addict Biol·2003
7-preclinical
Carvedilol attenuates neuroleptic-induced orofacial dyskinesia: possible antioxidant mechanisms.
PMID 12010767·Br J Pharmacol·2002
4-observational
Differential effects of cyclooxygenase inhibitors on haloperidol-induced catalepsy.
PMID 12369252·Prog Neuropsychopharmacol Biol Psychiatry·2002
4-observational
Effect of 5-HT1A and 5-HT2A/2C receptor modulation on neuroleptic-induced vacuous chewing movements.
PMID 11779040·Eur J Pharmacol·2001
7-preclinical
Reversal of neuroleptic-induced orofacial dyskinesia by 5-HT3 receptor antagonists.
PMID 11408032·Eur J Pharmacol·2001
7-preclinical
Excitatory mechanisms in neuroleptic-induced vacuous chewing movements (VCMs): possible involvement of calcium and nitric oxide.
PMID 11485057·Behav Pharmacol·2001
7-preclinical
Possible involvement of prostaglandins in haloperidol-induced orofacial dyskinesia in rats.
PMID 11711046·Eur J Pharmacol·2001
7-preclinical
Differential role of dopamine D1 and D2 receptors in isoniazid-induced vacuous chewing movements.
PMID 11346896·Methods Find Exp Clin Pharmacol·2000
7-preclinical
Evaluation of prevalent phytocannabinoids in the acetic acid model of visceral nociception.
PMID 19679411·Drug Alcohol Depend·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3401 CIVIC CENTER BLVD
PHILADELPHIA, PA 19104 - Phone
- (215) 590-1000
Quick Facts
- NPI
- 1952512121
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 21
- Publications
- 20
Are you this provider?
Claim Your Profile